Cutting edge: Impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick Type C1 protein

Journal of Immunology

Volumn 177, Issue 1, 2006, Pages 26-30

  Sagiv, Yuval ^a   Hudspeth, Kelly ^a   Mattner, Jochen ^a   Schrantz, Nicolas ^b   Stern, Randi K ^a   Zhou, Dapeng ^c   Savage, Paul B ^d   Teyton, Luc ^b   Bendelac, Albert ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD1D ANTIGEN; CHOLESTEROL; GLYCOSPHINGOLIPID; MEMBRANE PROTEIN; NIEMANN PICK TYPE C1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL TRANSPORT; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENDOSOME; FEMALE; GENE MUTATION; LIPID TRANSPORT; LYMPHOCYTE DEPLETION; LYMPHOCYTE DIFFERENTIATION; LYSOSOME; MALE; MOUSE; NATURAL KILLER T CELL; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; SPHINGOMONAS; T LYMPHOCYTE SUBPOPULATION;

EID: 33745291927     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.1.26     Document Type: Article

References (41)

1. Ioannou, Y. A. 2000. The structure and function of the Niemann-Pick C1 protein. Mol. Genet. Metab. 71: 175-181.
2. Scott, C., and Y. A. Ioannou. 2004. The NPC1 protein: structure implies function. Biochim. Biophys. Acta. 1685: 8-13.
3. Parterson, M. C., M. T. Vanier, K. Suzuki, J. A. Morris, E. D. Carstea, E. B. Neufeld, et al. 2001. Neimann-Pick disease C: a lipid trafficking disorder. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. Beaudet, W. S. Sly, and D. Valle, eds. McGraw-Hill, New York, pp. 2625-2639.
4. Pentchev, P. G., M. E. Comly, H. S. Kruth, M. T. Vanier, D. A. Wenger, S. Patel, and R. O. Brady. 1985. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc. Natl. Acad. Sci. USA 82: 8247-8251.
5. Liscum, L., R. M. Ruggiero, and J. R. Faust. 1989. The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. J. Cell Biol. 108: 1625-1636.
6. Cruz, J. C., S. Sugii, C. Yu, and T. Y. Chang. 2000. Role of Niemann-Pick type C1 protein in intracellular trafficking of low density lipoprotein-derived cholesterol. J. Biol. Chem. 275: 4013-4021.
7. Vanier, M. T. 1999. Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature. Neurochem. Res. 24: 481-489.
8. Liscum, L. 2000. Niemann-Pick type C mutations cause lipid traffic jam. Traffic 1: 218-225.
9. Marks, D. L., and R. E. Pagano. 2002. Endocytosis and sorting of glycosphingolipids in sphingolipid storage disease. Trends Cell Mol. 12: 605-613.
10. Mukherjee, S., and F. R. Maxfield. 2004. Lipid and cholesterol trafficking in NPC. Biochim. Biophys. Acta. 1685: 28-37.
11. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
12. Park, S. H., and A. Bendelac. 2000. CD1-restricted T-Cell responses and microbial infection. Nature 406: 788-792.
13. Sandhoff, K., T. Kolter, and G. Van Echten-Deckert. 1998. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell. Ann. NY Acad. Sci. 845: 139-151.
14. Zhou, D., C. Cantu III, Y. Sagiv, N. Schrantz, A. B. Kulkarni, X. Qi, D. J. Mahuran, C. R. Morales, G. A. Grabowski, K. Benlagha, et al. 2004. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303: 523-527.
15. Kang, S. J., and P. Cresswell. 2004. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 5: 175-181.
16. Winau, F., V. Schwierzeck, R. Hurwitz, N. Remmel, P. A. Sieling, R. L. Modlin, S. A. Porcelli, V. Brinkmann, M. Sugita, K. Sandhoff, et al. 2004. Saposin C is required for lipid presentation by human CD1b. Nat. Immunol. 5: 169-174.
17. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
18. Sriram, V., W. Du, J. Gervay-Hague, and R. R. Brutkiewicz. 2005. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35: 1692-1701.
19. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434; 525-529.
20. Kinjo, Y., D. Wu, G. Kim, G. W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
21. Brozovic, S., T. Nagaishi, M. Yoshida, S. Betz, A. Salas, D. Chen, A. Kaser, J. Glickman, T. Kuo, A. Little, et al. 2004. CD1d function is regulated by microsomal triglyceride transfer protein. Nat. Med. 10: 535-539.
22. Dougan, S. K., A. Salas, P. Rava, A. Agyemang, A. Kaser, J. Morrison, A. Khurana, M. Kronenberg, C. Johnson, M. Exley, et al. 2005. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J. Exp. Med. 202: 529-539.
23. + T cell development and early IL-4 production in CD1-deficient mice. Immunity 6: 459-467.
24. Chiu, Y. H., J. Jayawardena, A. Weiss, D. Lee, S. H. Park, A. Dautry-Varsat, and A. Bendelac. 1999. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189: 103-110.
25. Higaki, K., H. Ninomiya, Y. Sugimoto, T. Suzuki, M. Taniguchi, H. Niwa, P. G. Pentchev, M. T. Vanier, and K. Ohno, 2001. Isolation of NPC1-deficient Chinese hamster ovary cell mutants by gene trap mutagenesis. J. Biochem. 129:875-880.
26. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluotescent CD1d tetramers. J. Exp. Med. 191: 1895-1903.
27. + T lymphocytes. Science 268:863-865.
28. Zhou, X. T., C. Forestier, R. D. Goff, C. Li, L. Teyton, A. Bendelac, and P. B. Savage. 2002. Synthesis and NKT cell stimulating properties of fluorophore- and biotin-appended 6"-amino-6"-deoxy- galactosylceramides. Org. Lett. 4: 1267-1270.
29. Pagano, R. E., and R. G. Sleight. 1985. Defining lipid transport pathways in animal cells. Science 229: 1051-1057.
30. Schwarzmann, G., and K. Sandhoff. 1990. Metabolism and intracellular transport of glycosphingolipids. Biochemistry 29: 10865-10871.
31. Koval, M., and R. E. Pagano. 1990. Sorting of an internalized plasma membrane lipid between recycling and degradative pathways in normal and Niemann-Pick, type A fibroblasts. J. Cell Biol. 111:429-442.
32. Mayor, S., J. F. Presley, and F. R. Maxfield. 1993. Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J. Cell Biol. 121: 1257-1269.
33. Kok, J. W., K. Hoekstra, S. Eskelinen, and D. Hoekstra. 1992. Recycling pathways of glucosylcetamide in BHK cells: distinct involvement of early and late endosomes. J. Cell Sci. 103 (Pt 4): 1139-1152.
34. Pagano, R. E., O. C. Martin, H. C. Kang, and R. P. Haugland. 1991. A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor. J. Cell Biol. 113: 1267-1279.
35. Sun, X., D. L. Marks, W. D. Park, C. L. Wheatley, V. Puri, J. F. O'Brien, D. L. Kraft, P. A. Lundquist, M. C. Patterson, R. E. Pagano, and K. Snow. 2001. Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPCl. Am. J. Hum. Genet. 68: 1361-1372.
36. Chen, C. S., M. C. Patterson, C. L. Wheatley, J. F. O'Brien, and R. E. Pagano. 1999. Broad screening test for sphingolipid-storage diseases. Lancet 354: 901-905.
37. Chiu, Y. H., S. H. Park, K. Benlagha, C. Forestier, J. Jayawardena-Wolf, P. B. Savage, L. Teyton, and A. Bendelac. 2002. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat. Immunol. 3: 55-60.
38. Honey, K., K. Benlagha, C. Beers, K. Fotbush, L. Teyton, M. J. Kleijmeer, A. Y. Rudensky, and A. Bendelac. 2002. Thymocyte expression of carhepsin L is essential for NKT cell development. Nat. Immunol. 3: 1069-1074.
39. Sranic, A. K., A. D. De Silva, J. J. Park, V. Sriram, S. Ichikawa, Y. Hirabyashi, K. Hayakawa, L. Van Kaer, R. R. Brutkiewicz, and S. Joyce. 2003. Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency. Proc. Natl. Acad. Sci. USA 100:1849-1854.
40. Sillence, D. J., V. Puri, D. L. Marks, T. D. Butters, R. A. Dwek, R. E. Pagano, and F. M. Platt. 2002. Glucosylceramide modulates membrane traffic along the endocytic pathway. J. Lipid Res. 43: 1837-1845.
41. te Vruchte, D., E. Lloyd-Evans, R. J. Veldman, D. C. Neville, R. A. Dwek, F. M. Platt, W. J. van Blitterswijk, and D. J. Sillence. 2004. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J. Biol. Chem. 279: 26167-26175.